Rapid Education on COVID-19 Outpatient Treatment

Concept of SACS CoV2 or Coronavirus Stock Photo

During the COVID-19 pandemic, major breakthroughs have been made on the identifications of viral strains/RNA sequences, viral receptors, and their partners, as well as development of effective vaccines.

Importantly, molecular mechanisms underlying the pathogenesis of COVID-19 are far from being fully understood. Since SARS-CoV-2 receptor angiotensin converting enzyme 2 (ACE2) is highly expressed in the cardiovascular system, and that organ failure of the heart and lungs represents major pathological features of COVID-19, it is important to familiarize healthcare professionals with the latest progress on the phenotypes and mechanisms of systemic injuries during the pathogenesis of COVID-19 to facilitate deploying appropriate therapeutic treatment.1

Digital Learning Activities

Digital Learning Activities have emerged as an increasingly effective tool for CE and knowledge dissemination. The Digital Learning Activities offer the learner threaded bits of instruction on a specific topic in an easily consumable format. A better-informed healthcare workforce contributes to improved patient outcomes. Earn 0.5 CE credits per Digital Learning Activity.

Register for these Digital Learning Activities below and earn available CE, AAFP, and ABIM MOC Credits.

HeartBEATS from Lifelong Learning™

Logo HeartBEATS from Lifelong Learning

SARS-CoV-2 and the Omicron Variant:

The Viral Lifecyle and Therapeutic Implications for Primary Care

COVID-19 care is now mostly provided outside of hospital settings. Early diagnosis and therapeutic intervention for those who are at increased risk of progression to severe COVID-19 may improve outcomes. Dr. Jeff Hsu talks with Dr. Mary Brennan about the symptoms associated with the different stages of SARS-CoV-2 and choosing the appropriate outpatient therapeutic treatment. CE and ABIM MOC credits available.

Heart Health Unmasked COVID and Cardiac Wellness

It has been essential for healthcare professionals to be responsive to emerging knowledge from the scientific community to manage patients contracting the SARS-CoV-2 illness. Dr. Jeff Hsu talks with Dr. Carrie Harvey about the cardiovascular risks with COVID-19, diagnostic tools, clinical manifestations, short and long-term cardiovascular outcomes after recovery from the acute infection.

Guidelines and Articles

COVID-19 and Cardiovascular Disease | Circulation Research (ahajournals.org)
Chung MK, Zidar DA, Bristow MR, et al. COVID-19 and cardiovascular disease. Circulation Research. 2021; 128:1214-1236 doi.org/10.1161/CIRCRESAHA.121.317997

Viruses | Free Full-Text | Impact of COVID-19 on Cardiovascular Disease (mdpi.com)
Vosko I, Zirlik A, Bugger H. Impact of COVID-19 on Cardiovascular Disease. Viruses. 2023 Feb 11;15(2):508. doi: 10.3390/v15020508. PMID: 36851722; PMCID: PMC9962056.

Racial and Ethnic Disparities in Heart and Cerebrovascular Disease Deaths During the COVID-19 Pandemic in the United States | Circulation (ahajournals.org)
Wadhera RK, Figueroa JF, Rodriguez F, et al. Racial and Ethnic Disparities in Heart and Cerebrovascular Disease Deaths During the COVID-19 Pandemic in the United States. Circulation. 2021 Jun 15;143(24):2346-2354. doi: 10.1161/CIRCULATIONAHA.121.054378.


1. Trougakos IP, Stamatelopoulos K, Terpos E, et al. Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications. J Biomed Sci 28, 9 (2021). https://doi.org/10.1186/s12929-020-00703-5.c.

This program is supported by a medical educational grant from grant from Pfizer.